Skip to main content

Antiplatelet therapy and atherosclerotic events. Risks and patients' values need to be included in decision about aspirin for prevention of coronary heart disease.

Publication ,  Journal Article
Pignone, M; Mulrow, C
Published in: BMJ
April 13, 2002

Duke Scholars

Published In

BMJ

EISSN

1756-1833

Publication Date

April 13, 2002

Volume

324

Issue

7342

Start / End Page

917

Location

England

Related Subject Headings

  • Risk Factors
  • Platelet Aggregation Inhibitors
  • Patient Selection
  • Humans
  • General & Internal Medicine
  • Coronary Disease
  • Aspirin
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
 

Published In

BMJ

EISSN

1756-1833

Publication Date

April 13, 2002

Volume

324

Issue

7342

Start / End Page

917

Location

England

Related Subject Headings

  • Risk Factors
  • Platelet Aggregation Inhibitors
  • Patient Selection
  • Humans
  • General & Internal Medicine
  • Coronary Disease
  • Aspirin
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences